So far Sunday, July 19, NASDAQ is down -1.01% and the S&P is down -0.16%. Let’s take a look at
Leaders and laggards in the COVID-19 vaccine race -- and how likely they are to win approval.
So far Saturday, July 18, NASDAQ is down -1.01% and the S&P is down -0.16%. Let’s take a look at
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
A coronavirus vaccine has the potential to not only save countless lives, but also to mitigate trillions in economic damage.
America's highest-profile medical professional waxes optimistic on the potential for a "safe and effective" vaccine by 2021.
U.S. stocks were wavering Friday in the face of slumping U.S. consumer sentiment and escalating rates of coronavirus infections. Consumer sentiment last month missed economists' forecasts, falling to
Investors need a bevy of high-growth stocks as part of every well-rounded biotech portfolio, and the market's furor surrounding the prospect of a COVID-19 vaccine creates the perfect conditions for th
Debt-free and in the limelight, strong fundamentals mean these companies have ample financial headroom for aggressive growth. The post 4 Debt-Free Companies With Strong Stocks to Buy appeared first o
It's a great time to be a small biotech focused on fighting COVID-19. Inovio Pharmaceuticals (NASDAQ: INO) stock has skyrocketed more than 600% higher so far this year. Shares of Sorrento Therape
These three vaccine stocks show no signs of slowing down their breathtaking pace of growth.
These high-flying biotechs have high hopes for their COVID-19 programs.
(Bloomberg) -- Manila, capital of the Philippines, may return to a lockdown as coronavirus cases rise while Jakarta in Indonesia keeps social-distancing measures set to expire amid a surge in cases. A
Stocks Analysis by Investing.com (Tezcan Gecgil/Investing.com) covering: Vertex Pharmaceuticals Inc, Gilead Sciences Inc, iShares Nasdaq Biotechnology ETF, Amgen Inc. Read Investing.com (Tezcan Gecgil

Should Inovio's Lawsuits Worry Investors?

11:02am, Thursday, 16'th Jul 2020
Inovio Pharmaceuticals (NASDAQ: INO) has been around for nearly 40 years. The pandemic turned out to be a huge catalyst for Inovio, however, after the biotech began developing a vaccine candidate for
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE